EMAIL THIS PAGE TO A FRIEND

Analytica chimica acta

Preparation, characterization and application of N-methylene phosphonic acid chitosan grafted magnesia-zirconia stationary phase.


PMID 25479884

Abstract

A hydrophilic stationary phase (SP) was prepared through grafting N-methylene phosphonic acid chitosan on magnesia-zirconia particles (P-CTS-MgO-ZrO2) via Lewis acid-base interaction. The resulting material was characterized by thermogravimetric analysis, Fourier transform infrared spectroscopy, scanning electron microscope and nitrogen adsorption analysis. The chromatographic performance of P-CTS-MgO-ZrO2 was systemically evaluated by studying effect of acetonitrile content, pH and buffer concentration in the mobile phase. The results demonstrated that the novel SP provided hydrophilic, electrostatic-repulsion and ion-exchange interactions. Compared to the bare MgO-ZrO2, P-CTS-MgO-ZrO2 exhibited superior peak shape, reasonable resolution and reduced analysis time in separation of basic analytes. Besides, remarkable resolving power of acids, i.e. six non-steroidal anti-inflammatory drugs which failed to be eluted from the bare MgO-ZrO2, was obtained with the theoretical plate number (N/m) of 4653-31313, asymmetry factor <1.21 and the resolution of 1.6-3.4. Finally, P-CTS-MgO-ZrO2 SP was applied to separate monosaccharides, phospholipids and peptides. P-CTS-MgO-ZrO2 was a promising hydrophilic SP for wide applications.

Related Materials

Product #

Image

Description

Molecular Formula

Add to Cart

W379301
D-(−)-Ribose, ≥98%
C5H10O5
R1757
D-(−)-Ribose, 98%
C5H10O5
R7500
D-(−)-Ribose, ≥99%
C5H10O5
R9629
D-(−)-Ribose, suitable for cell culture, BioReagent
C5H10O5
R9633
D-(−)-Ribose, plant cell culture tested, BioReagent
C5H10O5
215112
Phosphorous acid, 99%
H3O3P
S8626
Sulfadiazine, ≥99.0%
C10H10N4O2S
35033
Sulfadiazine, VETRANAL, analytical standard
C10H10N4O2S
S1800000
Sulfadiazine, European Pharmacopoeia (EP) Reference Standard
C10H10N4O2S
1625009
Sulfadiazine, United States Pharmacopeia (USP) Reference Standard
C10H10N4O2S
PHR1343
Sulfadiazine, Pharmaceutical Secondary Standard; Certified Reference Material
C10H10N4O2S
Y0001480
Sulfadiazine for identification of impurity F, European Pharmacopoeia (EP) Reference Standard
C10H10N4O2S
S1900000
Sulfadimidine, European Pharmacopoeia (EP) Reference Standard
C12H14N4O2S
Y0001495
Sulfadimidine for peak identification, European Pharmacopoeia (EP) Reference Standard
C12H14N4O2S
S8876
Sulfamerazine, ReagentPlus®, ≥99.0%
C11H12N4O2S
46826
Sulfamerazine, VETRANAL, analytical standard
C11H12N4O2S
S2000000
Sulfamerazine, European Pharmacopoeia (EP) Reference Standard
C11H12N4O2S
S6256
Sulfamethazine, ≥99%
C12H14N4O2S
46802
Sulfamethazine, VETRANAL, analytical standard
C12H14N4O2S
46902
Sulfathiazole, VETRANAL, analytical standard
C9H9N3O2S2
S2158000
Sulfathiazole, European Pharmacopoeia (EP) Reference Standard
C9H9N3O2S2
S9876
Sulfathiazole, analytical standard, ≥98.0%
C9H9N3O2S2
X0200000
Xylose, European Pharmacopoeia (EP) Reference Standard
C5H10O5